Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms-Reference-Cited by-同舟云学术

Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms

Published:2019-01 Issue:1 Volume:15 Page:86-97
ISSN:1549-9634
Container-title:Nanomedicine: Nanotechnology, Biology and Medicine
language:en
Short-container-title:Nanomedicine: Nanotechnology, Biology and Medicine

Author:

Zhang Yan-Qiong,Shen Yan,Liao Ming-Mei,Mao Xia,Mi Gu-Jie,You Chen,Guo Qiu-Yan,Li Wei-Jie,Wang Xiao-Yue,Lin Na,Webster Thomas J.

Funder

National Natural Science Foundation of China

Beijing Nova Program

Fundamental Research Funds for the Central Public Welfare Research Institutes

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Materials Science,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering

Reference44 articles.

1. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world;Dimitroulis;World J Gastroenterol,2017

2. The biology of hepatocellular carcinoma: implications for genomic and immune therapies;Khemlina;Mol Cancer,2017

3. Systemic treatment of hepatocellular carcinoma: Past, present and future;Cidon;World J Hepatol,2017

4. Hepatocellular carcinoma: Will novel targeted drugs really impact the next future?;Montella;World J Gastroenterol,2016

5. A novel melittinnano-liposome exerted excellent anti-hepatocellular carcinoma efficacy with better biological safety;Mao;J Hematol Oncol,2017

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomedicine-induced programmed cell death in cancer therapy: mechanisms and perspectives;Cell Death Discovery;2024-08-29

2. Chitosan-based biomaterial delivery strategies for hepatocellular carcinoma;Frontiers in Pharmacology;2024-08-05

3. Recent advances in nano-based drug delivery systems for treatment of liver cancer;Journal of Pharmaceutical Sciences;2024-08

4. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges;Drug Delivery and Translational Research;2024-07-13

5. Navigating liver targeting: Fine-tuning chitosan nanocarriers through saccharide modification;Journal of Drug Delivery Science and Technology;2024-05